Chitransh Groups Pvt. Ltd. is a trusted medical device regulatory consulting agency that supports manufacturers in meeting regulatory requirements and achieving sustainable business growth. We provide complete end-to-end consultancy services for the healthcare industry, covering product design and development, manufacturing facility planning, documentation, and regulatory approvals at both national and international levels. Our expertise includes turnkey solutions, Quality Management System (QMS) implementation, regulatory strategy planning, training programs, licensing, certifications, and approval support. We carefully analyze each client’s requirements and provide customized solutions that ensure compliance with applicable regulatory standards while maintaining cost efficiency and timelines.

We have worked with a wide range of clients, including innovative startups, growing manufacturers, and well-established global medical device companies. Our experienced technical and regulatory professionals bring strong industry knowledge and hands-on experience, enabling us to deliver practical and reliable solutions for complex regulatory challenges. At Chitransh Groups, we focus on high-quality standards, timely project execution, and long-term compliance. Under the leadership of Rahul Priyadarshi, Director of Chitransh Groups Pvt. Ltd., the organization continues to deliver reliable and globally aligned regulatory solutions. We assist companies in implementing robust Quality Management Systems (QMS) to ensure the safety, performance, and effectiveness of medical devices for end users. We also provide worldwide regulatory consulting services, helping clients expand into global markets without regulatory barriers. Our regulatory expertise spans multiple international markets, including the United Kingdom, United States, Saudi Arabia, South Africa, Germany, Brazil, Egypt, the Netherlands, Oman, Costa Rica, and Iran. Contact us today for a complimentary consultation and discover how we can support your regulatory compliance and global expansion goals.